-
Alzheimer’s Disease: Expert Insights From ICAD 2011
CME Review key data regarding the pathophysiology of AD, safety and efficacy of current and emerging treatments; and results of clinical trials
May 2012
-
Increased Risk for MI Seen in Elderly Patients Taking Antipsychotics
CME Antipsychotic drugs used to treat symptoms in elderly patients with dementia are associated with an increased risk for myocardial infarction, especially during the first month of use.
Medscape Education Clinical Briefs, April 2012
-
Four Questions May Assist Clinicians in Detecting aMCI
CME Four questions from the Alzheimer's Questionnaire may help clinicians differentiate normal age-related memory loss from amnestic mild cognitive impairment, a risk factor for Alzheimer's disease.
Medscape Education Clinical Briefs, March 2012
-
Mediterranean Diet May Lower Risk for Brain Vascular Disease
CME A diet rich in vegetables, legumes, fruits, and olive oil seems to lower white matter hyperintensity volume on brain magnetic resonance imaging, thus lowering small-vessel disease in the brain.
Medscape Education Clinical Briefs, February 2012
-
Revised MCI Criteria May Overlap Diagnosis of AD Dementia
CME The categoric distinction between mild cognitive impairment and milder stages of Alzheimer's dementia has been compromised by the revised criteria for mild cognitive impairment.
Medscape Education Clinical Briefs, February 2012
-
Panel Revises Guidelines on Assessment of AD
CME/CE A panel from the United States and Europe has completed updating the 1997 consensus guidelines for the neuropathologic assessment of Alzheimer's disease.
Medscape Education Clinical Briefs, February 2012
-
Community CME: Headaches in a 'Haunted' House
CME 72-year-old woman with headache, nausea, and "hearing ghosts." What is the best therapeutic approach for this patient? Find out the differential generated by colleagues and how the case resolved.
Medscape Education Family Medicine, February 2012
-
Antipsychotics Vary in Mortality Risks in Dementia Treatment
CME There may be differences in mortality risks among individual antipsychotic agents used for treating patients with dementia.
Medscape Education Clinical Briefs, January 2012
-
Elevated Adiponectin Levels May Increase Dementia Risk in Women
CME New data from the Framingham Heart Study suggest that increased adiponectin levels may be an independent risk factor for all-cause dementia and Alzheimer's disease in women.
Medscape Education Clinical Briefs, January 2012
-
Cognitive Decline Detectable Even in Middle-Aged Adults
CME In a longitudinal study, average performance in various cognitive domains declined in all age groups in a period of 10 years, including persons 45 to 49 years old.
Medscape Education Clinical Briefs, January 2012
-
Diagnosis of Dementia Increases Risk for Suicide
CME A new study shows that a diagnosis of dementia increases an individual's risk for suicide, especially in the setting of depression and anxiety.
Medscape Education Clinical Briefs, November 2011
-
ARBs May Reduce Risk for Alzheimer's and Other Dementia
CME Blood pressure control with an angiotensin II receptor blocker vs other antihypertensive drugs reduced the risk for Alzheimer's disease and vascular dementia, according to an observational study.
Medscape Education Clinical Briefs, November 2011
-
Distinguishing Alzheimer Disease From Other Major Forms of Dementia
CME Alzheimer disease encompasses a broad spectrum from preclinical, to mild cognitive impairment, to AD dementia; diagnosis requires AD biomarkers.
Expert Review of Neurotherapeutics, November 2011
-
Do Anticholinergics Lead to Further Cognitive Decline?
CME/CE Taking medication with a low level of anticholinergic activity does not appear to cause further cognitive impairment or more rapid cognitive decline in patients with established Alzheimer's disease.
Medscape Education Clinical Briefs, October 2011
-
No Cognitive Benefit Seen in Intensive Blood Glucose Lowering
CME A study comparing standard vs more intensive lowering of blood glucose levels in patients with type 2 diabetes shows no significant differences in cognitive outcomes.
Medscape Education Clinical Briefs, October 2011
-
Few Benefits, Significant Adverse Effects Linked With Off-Label Atypical Use
CME/CE A meta-analysis found significant increases in behavioral symptom scores in certain groups of patients receiving off-label atypical antipsychotics, but serious adverse effects were reported.
Medscape Education Clinical Briefs, October 2011
-
Memory Complaints Useful in Cognitive Assessment of Older Patients
CME The type and number of older patients' memory complaints can be useful in helping to decide whether follow-up cognitive assessment is warranted, according to a new study.
Medscape Education Clinical Briefs, October 2011
-
Late-Life Depression Potential Indicator of Dementia Risk
CME Late-life depression, occurring after age 50 years, is linked with a significantly increased risk for dementia, according to a new study.
Medscape Education Clinical Briefs, September 2011
-
Cognitive Tests Predict AD Better Than Biomarkers
CME/CE Changes in cognitive function outperformed biomarkers for predicting conversion from mild cognitive impairment to Alzheimer's disease, but caution should be followed in interpreting these results.
Medscape Education Clinical Briefs, September 2011
-
Aerobic Exercise May Help Reduce Risk for Dementia
CME/CE A recent review study found that any form of aerobic physical activity has a positive effect on the brain and may reduce the risk for dementia or slow cognitive decline.
Medscape Education Clinical Briefs, September 2011
